Innovative Product Portfolio ACEA Biosciences offers cutting-edge cell analysis platforms like xCELLigence Real-Time Cell Analysis instruments and NovoCyte flow cytometers, which are widely used in pre-clinical research, drug discovery, and toxicology. Their demonstrated usage in over 1,800 peer-reviewed publications indicates strong industry credibility and potential as a target for laboratories seeking reliable research tools.

Strong Industry Presence With more than 2,500 instruments installed globally, ACEA Biosciences has established a significant footprint in the life sciences research sector. This extensive installed base presents opportunities for upselling advanced software, accessories, and service solutions to existing clients, as well as expanding into new markets and research institutions.

Recent Innovation Launches Recent product launches, including a high-performance 4-Laser Benchtop Flow Cytometer and advanced data analysis software like xCELLigence RTCA Software Pro and NovoExpress, highlight ongoing innovation. These new offerings open doors for sales conversations around hardware upgrades, software adoption, and integrated research solutions.

Industry Focus & Collaborations ACEA's partnership with the Cancer Research Institute reflects a strategic focus on cancer immunotherapy research. Engaging with similar research-focused organizations offers opportunities for tailored solutions, sponsored research collaborations, and funding programs that can drive product adoption.

Acquisition by Agilent Being part of Agilent Technologies enhances ACEA’s credibility and broadens its sales prospects through access to a larger distribution network and resources. Leveraging this relationship, sales teams can target a broader ecosystem of biotech and pharmaceutical clients seeking integrated research tools and solutions.